PAM
ATXS

Panagora Asset Management’s Astria Therapeutics ATXS Stock Holding History

Panagora Asset Management’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-169,144
Closed -$1.23M – 1178
2025
Q3 		$1.23M Buy
169,144
+70,686
+72% +$478K 0.01% 622
2025
Q2 		$528K Buy
+98,458
New +$477K ﹤0.01% 788
2024
Q3 		– Sell
-30,926
Closed -$281K – 1201
2024
Q2 		$281K Buy
30,926
+15,816
+105% +$154K ﹤0.01% 1051
2024
Q1 		$213K Sell
15,110
-352
-2% -$4.38K ﹤0.01% 1147
2023
Q4 		$119K Buy
+15,462
New +$85.5K ﹤0.01% 1200
2021
Q1 		– Sell
-46
Closed -$1K – 2818
2020
Q4 		$1K Sell
46
-1,545
-97% -$27.5K ﹤0.01% 2696
2020
Q3 		$59K Buy
1,591
+46
+3% +$1.82K ﹤0.01% 1970
2020
Q2 		$60K Buy
+1,545
New +$55K ﹤0.01% 1929
2019
Q3 		– Sell
-1,121
Closed -$54K – 2473
2019
Q2 		$54K Sell
1,121
-328
-23% -$14.9K ﹤0.01% 2076
2019
Q1 		$69K Buy
1,449
+67
+5% +$2.27K ﹤0.01% 1969
2018
Q4 		$36K Sell
1,382
-26
-2% -$985 ﹤0.01% 2053
2018
Q3 		$68K Sell
1,408
-67
-5% -$3.01K ﹤0.01% 1953
2018
Q2 		$85K Buy
1,475
+770
+109% +$71K ﹤0.01% 1890
2018
Q1 		$77K Hold
705
– – ﹤0.01% 1914
2017
Q4 		$63K Buy
705
+248
+54% +$29.2K ﹤0.01% 2013
2017
Q3 		$58K Sell
457
-101
-18% -$8.42K ﹤0.01% 2024
2017
Q2 		$48K Buy
+558
New +$46.5K ﹤0.01% 2077

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Panagora Asset Management's ATXS Position: Q4 2025 in Review

Panagora Asset Management sold out of Astria Therapeutics (ATXS) in Q4 2025, closing a stake of 169,144 shares — an estimated $1.23M sold.

Panagora Asset Management first reported a position in ATXS in Q2 2017 and held it in 17 quarters. The position peaked at $1.23M in Q3 2025. 141 funds tracked by Wall St. Rank hold ATXS as of Q4 2025.

  • Panagora Asset Management reported no remaining Astria Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Panagora Asset Management sold 169,144 Astria Therapeutics shares in Q4 2025, an estimated $1.23M.
  • Panagora Asset Management first reported a position in Astria Therapeutics in Q2 2017 and held it in 17 quarters.
  • Panagora Asset Management's Astria Therapeutics position peaked at $1.23M in Q3 2025.
  • 141 funds tracked by Wall St. Rank held Astria Therapeutics as of Q4 2025.

Based on Panagora Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.